Staar Surgical (STAA) EBIT (2010 - 2026)

Staar Surgical has reported EBIT for 17 years, with the latest figure at $8.0 million in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 113.9% year-over-year to $8.0 million; the trailing twelve-month figure through Apr 2026 stood at -$26.3 million (up 53.82% YoY), and the FY2026 full-year result was -$91.7 million, down 4724.46% from the prior year.
• EBIT for Q2 2026 stood at $8.0 million, up from -$22.8 million in the prior quarter.
• The five-year high for EBIT was $18.5 million in Q3 2025, with the low at -$57.4 million in Q1 2025.
• Historically, EBIT has averaged -$808000.0 across 5 years, with a median of $6.3 million in 2023.
• Annual changes were most pronounced in 2023 — EBIT soared 979.36% — and 2025, when it plunged 2416.48%.
• Staar Surgical's EBIT stood at $964000.0 in 2022, then soared by 979.36% to $10.4 million in 2023, then tumbled by 265.31% to -$17.2 million in 2024, then surged by 207.5% to $18.5 million in 2025, then tumbled by 56.85% to $8.0 million in 2026.
• The last three EBIT figures came in at $8.0 million (Q2 2026), -$22.8 million (Q1 2026), and $18.5 million (Q3 2025), per Business Quant data.